Associated Evidence Record
Evidence for
The Saransk EPO Finding Behind Emelyanov’s Eight-Year Ban
Companion notes
Stanislav Emelyanov’s Saransk Out-of-Competition Doping Case
This companion separates what the official arbitration award establishes from what contemporary reporting and federation statements add or leave uncertain. It identifies which records support each material claim about Emelyanov’s sanctions, the Saransk finding, and the later CAS proceeding.
Arbitral Record and Sanction Authority
The CAS award is the controlling document for Emelyanov’s anti-doping sanctions. It records that he was a Russian race walker, that the ARAF Anti-Doping Commission imposed a two-year ineligibility on 15 December 2012, and that a later CAS proceeding imposed an eight-year period of ineligibility starting 7 April 2017. It also preserves the athlete biological passport analysis and the panel’s conclusion that the abnormal blood profile was highly likely caused by prohibited substances or methods. Because this is the arbitral disposition itself, it carries the greatest authority for the later sanction and the evidentiary basis accepted by the tribunal. [S2], [S8]
Contemporary Reporting and Federation Action
The Associated Press reporting supplies contemporaneous context that the CAS award does not attempt to narrate in full. Its dispatch on 22 September 2015 reported that Emelyanov was among six Russian race walkers suspended after failing out-of-competition tests in June in Saransk, and it noted Russian-media claims that his B sample was negative while the IAAF declined comment. That makes the AP piece useful as an independent snapshot of how the case was publicly framed before the later arbitration result, but not as a substitute for the adjudicative findings. [S4], [S2]
The IAAF’s 13 November 2015 press release is a separate official record addressing the federation’s broader response to Russian anti-doping noncompliance. It confirmed the provisional suspension of ARAF and published the competition consequences for Russian athletes and support personnel, including exclusion from international competition while the suspension remained in force. That statement is authoritative on the federation action, but it does not resolve Emelyanov’s individual merits; on that point, the CAS award remains the decisive source. [S7], [S2]
What the Public Record Still Does Not Resolve
The main documentary tension is between the media-reported negative B-sample claim and the later arbitral outcome built on EPO evidence and biological passport abnormalities. The available records show that the claim circulated publicly and went unanswered by the IAAF at the time, yet they do not provide the underlying laboratory chain or a tribunal ruling specifically adjudicating that B-sample allegation. For public-record purposes, the negative-B-sample point remains an unresolved reporting claim, not an established exculpation. [S4], [S2]
Claim provenance
| Claim | Supporting records | Independence | Qualification |
| C1 | [S2], [S4], [S8] | Court of Arbitration for Sport, Associated Press, wikipedia.org | This identifies his athletic role only. |
| C2 | [S2] | Court of Arbitration for Sport | The CAS award states this as the first violation. |
| C3 | [S2] | Court of Arbitration for Sport | The CAS award describes this as a separate prior violation sanctioned on 7 April 2017. |
| C4 | [S2], [S8] | Court of Arbitration for Sport, wikipedia.org | The Wikipedia entry is corroborative only; the operative source is the CAS award. |
| C5 | [S4] | Associated Press | The report attributes the suspension status to the IAAF and notes the June Saransk testing. |
| C6 | [S4] | Associated Press | This is an attributed reporting detail, not a finding on the merits. |
| C7 | [S7] | worldathletics.org | This is the federation-level action taken by the IAAF Council. |
| C8 | [S7] | worldathletics.org | This describes the published consequences of the provisional suspension. |
| C9 | [S2] | Court of Arbitration for Sport | This is the CAS award’s account of expert analysis, not an independent medical diagnosis. |
| C10 | [S2] | Court of Arbitration for Sport | This records his position and does not establish the truth of the denial. |
Source key
The associated evidence packet contains visible source URLs, source roles and the complete claim ledger.
Archival Sources & Verified Claims
Investigative question
What do the official arbitration record and contemporary reporting establish about Stanislav Emelyanov’s doping sanctions, the Saransk positive test, and the later CAS proceeding?
Event boundary
From Emelyanov’s first documented anti-doping sanction in December 2012 through the CAS award of 15 December 2017 addressing the 2015-2016 ABP profile and third-rule-violation charge.
Sources
Source 2 — TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov
Role: stage0 primary record
Independent source group: Court of Arbitration for Sport
URL: https://jurisprudence.tas-cas.org/pdf/5193.pdf
Primary authoritative record for the 2012 sanction, 2015 Saransk EPO case, ABP analysis, notice/charge process, and the 15 December 2017 CAS award.
Limit: This is an arbitral award summarizing facts and party submissions; it is authoritative for the proceeding but still distinguishes allegations, expert opinions, and findings.
Source 4 — Russian race walkers suspended after positive drug tests
Role: stage0 contemporary reporting
Independent source group: Associated Press
Contemporary AP reporting on the June 2015 Saransk testing and suspensions.
Limit: Contains attributed reporting and unresolved media references to a negative B sample; it does not itself adjudicate the case.
Source 7 — IAAF provisionally suspends Russian Member Federation ARAF (press release)
Role: court or inquiry
Independent source group: worldathletics.org
URL: https://worldathletics.org/news/press-release/iaaf-araf-suspended
Official IAAF press release on the provisional suspension of ARAF and the consequences for Russian athletes.
Limit: Federation statement; useful for institutional action and consequences, not for proving individual guilt.
Source 8 — Stanislav Emelyanov — Wikipedia entry
Role: reference
Independent source group: wikipedia.org
URL: https://en.wikipedia.org/wiki/Stanislav_Emelyanov
Background reference for identity, race-walking specialty, and later sanctions chronology.
Limit: Wikipedia is zero-authority for standalone factual proof and is used only where corroborated by TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov or Russian race walkers suspended after positive drug tests.
Claim ledger
| Item | Claim | Support | Qualification |
| Claim 1 | Stanislav Emelyanov was a Russian race walker. | TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov, Russian race walkers suspended after positive drug tests, Stanislav Emelyanov — Wikipedia entry | This identifies his athletic role only. |
| Claim 2 | On 15 December 2012, the ARAF Anti-Doping Commission sanctioned Emelyanov with a two-year period of ineligibility. | TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov | The CAS award states this as the first violation. |
| Claim 3 | On 2 June 2015, an out-of-competition doping test at the race-walking centre in Saransk produced an adverse analytical finding for EPO in Emelyanov’s case. | TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov | The CAS award describes this as a separate prior violation sanctioned on 7 April 2017. |
| Claim 4 | The Court of Arbitration for Sport imposed an eight-year period of ineligibility on Emelyanov starting on 7 April 2017 for the 2 June 2015 EPO finding. | TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov, Stanislav Emelyanov — Wikipedia entry | The Wikipedia entry is corroborative only; the operative source is the CAS award. |
| Claim 5 | The Associated Press reported on 22 September 2015 that Emelyanov was among six Russian race walkers suspended after failing doping tests in out-of-competition testing in June in Saransk. | Russian race walkers suspended after positive drug tests | The report attributes the suspension status to the IAAF and notes the June Saransk testing. |
| Claim 6 | The AP report said the IAAF declined to comment on reports in Russian media that Emelyanov’s B sample from the June testing had come back negative. | Russian race walkers suspended after positive drug tests | This is an attributed reporting detail, not a finding on the merits. |
| Claim 7 | The IAAF provisionally suspended ARAF on 13 November 2015. | IAAF provisionally suspends Russian Member Federation ARAF (press release) | This is the federation-level action taken by the IAAF Council. |
| Claim 8 | The 13 November 2015 IAAF press release stated that Russia’s athletes and athlete support personnel could not compete in international competitions, including the Olympic Games, while the provisional suspension remained in effect. | IAAF provisionally suspends Russian Member Federation ARAF (press release) | This describes the published consequences of the provisional suspension. |
| Claim 9 | The CAS award recorded that Emelyanov’s 2015-2016 athlete biological passport showed abnormal blood values and that an expert panel concluded the profile was highly likely caused by prohibited substances or methods. | TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov | This is the CAS award’s account of expert analysis, not an independent medical diagnosis. |
| Claim 10 | Emelyanov denied using a prohibited substance or prohibited method in his 22 February 2017 email to the IAAF. | TAS/CAS PDF (5193) - Award text for IAAF v. RUSAF & Stanislav Emelyanov | This records his position and does not establish the truth of the denial. |
Evidence assessment
The locked sources support a narrow, documented anti-doping case story rather than a sensationalized exile narrative: Emelyanov was a Russian race walker with an earlier 2012 sanction, was named in 2015 reporting about out-of-competition positives in Saransk, denied the allegation, and was later found by CAS to have committed another anti-doping violation based on abnormal ABP data tied by experts to blood manipulation or ESA use. The record also documents the IAAF’s provisional suspension of ARAF and the resulting restrictions on Russian athletes.
